Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay

Haemophilia(2021)10.1111/hae.14352Source: DataRank Database

Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay is a research paper published in Haemophilia (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.53)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Connie H. Miller ORCID

Live enrichment

PubMed:34089550 PMC:PMC8667261 OpenAlex:https://openalex.org/W3164555944

Intramural CDC HHS

Grant: CC999999

FWCI

0.53

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8667261

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14352

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/hae.14352

journalhttps://doi.org/10.1111/hae.14352

Fields of Study

Platelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and ThrombosisComplement system in diseasesAntibodiesBlood PlateletsFactor VIIIHumansvon Willebrand Disease, Type 3von Willebrand Diseasesvon Willebrand Factor

MeSH Terms

AntibodiesBlood PlateletsFactor VIIIHumansvon Willebrand Factorvon Willebrand Diseasesvon Willebrand Disease, Type 3

Keywords

Von Willebrand factorMedicineVon Willebrand diseasePlateletRefractory (planetary science)RistocetinAntibodyImmunologyAgglutination (biology)GastroenterologyInternal medicinePharmacologyBiologyInhibitorFactor VIII

Sustainable Development Goals

SDG 0: Good health and well-being